Latest & greatest articles for dementia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on dementia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on dementia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for dementia

1. Dementia wellbeing in the COVID-19 pandemic

Dementia wellbeing in the COVID-19 pandemic NHS England » Dementia wellbeing in the COVID-19 pandemic Cookies on the NHS England and NHS Improvement website We’ve put some small files called cookies on your device to make our site work. We’d also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site. Let us know if this is OK. We’ll use a cookie to save your choice. You can before you (...) choose. Change my preferences I'm OK with analytics cookies Search Search Menu . If you are a member of the public looking for health advice, go to the . And if you are looking for the latest travel information, and advice about the government response to the outbreak, go to the . Dementia wellbeing in the COVID-19 pandemic Document first published: 25 September 2020 Page updated: 9 October 2020 Topic: , Publication type: This resource is primarily for clinicians working with people with dementia

2020 NHS England

2. Supporting good quality, community-based end-of-life care for people living with dementia: the SEED research programme including feasibility RCT (Full text)

Supporting good quality, community-based end-of-life care for people living with dementia: the SEED research programme including feasibility RCT Supporting good quality, community-based end-of-life care for people living with dementia: the SEED research programme including feasibility RCT Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from (...) , Hatfield, UK 7 Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, UK 8 Dementia UK, London, UK 9 Medical School, University of Bristol, Bristol, UK 10 The Glasgow School of Art, Glasgow, UK 11 Yunus Centre for Social Business and Health, Glasgow Caledonian University, Glasgow, UK 12 Northumbria Healthcare NHS Foundation Trust, Newcastle upon Tyne, UK 13 Faculty of Medical Sciences, Professional Services, Newcastle University, Newcastle upon Tyne, UK 14 Marie Curie

2020 NIHR HTA programme PubMed abstract

3. Aromatherapy for dementia. (Abstract)

Aromatherapy for dementia. Medications licensed for the treatment of dementia have limited efficacy against cognitive impairment or against the distressed behaviours (behavioural and psychological symptoms, or behaviour that challenges) which are also often the most distressing aspect of the disorder for caregivers. Complementary therapies, including aromatherapy, are attractive to patients, practitioners and families, because they are perceived as being unlikely to cause adverse effects (...) . Therefore there is interest in whether aromatherapy might offer a safe means of alleviating distressed behaviours in dementia.To assess the efficacy and safety of aromatherapy for people with dementia.We searched ALOIS, the Cochrane Dementia and Cognitive Improvement Group Specialized Register, on 5 May 2020 using the terms: aromatherapy, lemon, lavender, rose, aroma, alternative therapies, complementary therapies, essential oils. In addition, we searched MEDLINE, Embase, PsycINFO (all via Ovid SP), Web

2020 Cochrane

4. Personally tailored activities for improving psychosocial outcomes for people with dementia in community settings. (Abstract)

Personally tailored activities for improving psychosocial outcomes for people with dementia in community settings. People with dementia living in the community, that is in their own homes, are often not engaged in meaningful activities. Activities tailored to their individual interests and preferences might be one approach to improve quality of life and reduce challenging behaviour.To assess the effects of personally tailored activities on psychosocial outcomes for people with dementia living (...) in the community and their caregivers. To describe the components of the interventions. To describe conditions which enhance the effectiveness of personally tailored activities in this setting.We searched ALOIS: the Cochrane Dementia and Cognitive Improvement Group's Specialized Register on 11 September 2019 using the terms: activity OR activities OR occupation* OR "psychosocial intervention" OR "non-pharmacological intervention" OR "personally-tailored" OR "individually-tailored" OR individual OR meaning

2020 Cochrane

5. A European Academy of Neurology guideline on medical management issues in dementia

A European Academy of Neurology guideline on medical management issues in dementia European Academy of Neurology guideline on the diagnosis of coma and other disorders of consciousness D. Kondziella a,b,c , A. Bender d,e , K. Diserens f , W. van Erp g,h , A. Estraneo i,j , R. Formisano k , S. Laureys g , L. Naccache l,m , S. Ozturk n , B. Rohaut l,m,o , J. D. Sitt m , J. Stender p , M. Tiainen q , A. O. Rossetti f, *, O. Gosseries g, * , and C. Chatelle g,r, * on behalf of the EAN Panel on Coma

2020 European Academy of Neurology

6. Recommendations of the 5th Canadian Consensus Conferenceon the diagnosis and treatment of dementia

Recommendations of the 5th Canadian Consensus Conferenceon the diagnosis and treatment of dementia Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia error_outline JavaScript disabled You have to enable JavaScript in your browser's settings in order to use the eReader. Or try downloading the content offline

2020 CPG Infobase

7. Improving mental health and reducing antipsychotic use in people with dementia in care homes: the WHELD research programme including two RCTs (Full text)

Improving mental health and reducing antipsychotic use in people with dementia in care homes: the WHELD research programme including two RCTs Improving mental health and reducing antipsychotic use in people with dementia in care homes: the WHELD research programme including two RCTs Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from (...) of Nottingham, Nottingham, UK 4 Faculty of Health and Social Care, Centre of Psychological Care and Ageing, University of Hull, Hull, UK 5 Dementia Service Development Centre, Wales Dementias & Neurodegenerative Diseases Network, Bangor University, Bangor, UK 6 Whitaker Research Ltd, Bangor, UK 7 Centre for Age-related Medicine, Stavanger University Hospital, University of Stavanger, Stavanger, Norway 8 Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK 9 London School

2020 NIHR HTA programme PubMed abstract

8. Care Interventions for People Living With Dementia and Their Caregivers

Care Interventions for People Living With Dementia and Their Caregivers Comparative Effectiveness Review Number 231 Care Interventions for People Living With Dementia and Their Caregivers Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 290-2015-00008-I Prepared by: Minnesota Evidence-based Practice Center Minneapolis, MN Investigators: Mary Butler, Ph.D., M.B.A. Joseph E (...) , the resulting surveillance report describing the methodology and findings will be found on the Effective Health Care Program Web site at www.effectivehealthcare.ahrq.gov. Search on the title of the report. Suggested citation: Butler M, Gaugler JE, Talley KMC, Abdi HI, Desai PJ, Duval S, Fort ML, Nelson VA, NG W, Ouellette JM, Ratner E, Saha J, Shippee T, Wagner BL, Wilt TJ, Yeshi L. Care Interventions for People Living With Dementia and Their Caregivers. Comparative Effectiveness Review No. 231. (Prepared

2020 Effective Health Care Program (AHRQ)

9. Amyloid PET in dementia of unclear aetiology

Amyloid PET in dementia of unclear aetiology 1 Translation of the executive summary of the assessment of potential Amyloid-PET bei Demenz unklarer Ätiologie (Version 1.0; Status: 29 May 2018). Please note: This translation is provided as a service by IQWiG to English- language readers. However, solely the German original text is absolutely authoritative and legally binding. Extract IQWiG Reports – Commission No. E18-03 Amyloid PET in dementia of unclear aetiology 1 Extract of assessment (...) of potential E18-03 Version 1.0 Amyloid PET in dementia of unclear aetiology 29 May 2018 Institute for Quality and Efficiency in Health Care (IQWiG) - i - Publishing details Publisher: Institute for Quality and Efficiency in Health Care Topic: Amyloid PET in dementia of unclear aetiology Commissioning agency: Federal Joint Committee Commission awarded on: 18 April 2018 Internal Commission No.: E18-03 Address of publisher: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen Im Mediapark 8 50670

2020 Institute for Quality and Efficiency in Healthcare (IQWiG)

10. Amyloid PET in dementia of unclear aetiology (Addendum to Commission E18-03)

Amyloid PET in dementia of unclear aetiology (Addendum to Commission E18-03) 1 Translation of the executive summary of the addendum Amyloid-PET bei Demenz unklarer Ätiologie – Addendum zum Auftrag E18-03 (Version 1.0; Status: 19 July 2018). Please note: This translation is provided as a service by IQWiG to English-language readers. However, solely the German original text is absolutely authoritative and legally binding. Extract IQWiG Reports – Commission No. E18-05 Amyloid PET in dementia (...) of unclear aetiology Addendum to Commission E18-03 1 Extract of addendum E18-05 Version 1.0 Amyloid PET in dementia of unclear aetiology 19 July 2018 Institute for Quality and Efficiency in Health Care (IQWiG) - i - Publishing details Publisher: Institute for Quality and Efficiency in Health Care Topic: Amyloid PET in dementia of unclear aetiology – Addendum to Commission E18-03 Commissioning agency: Federal Joint Committee Commission awarded on: 1 June 2018 Internal Commission No.: E18-05 Address

2020 Institute for Quality and Efficiency in Healthcare (IQWiG)

11. Dementia and mild cognitive impairment in prisoners aged over 50 years in England and Wales: a mixed-methods study (Full text)

Dementia and mild cognitive impairment in prisoners aged over 50 years in England and Wales: a mixed-methods study Dementia and mild cognitive impairment in prisoners aged over 50 years in England and Wales: a mixed-methods study Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find (...) the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} This study found a relatively high prevalence of dementia/mild cognitive impairment in prisons and it developed a care pathway and training materials for staff and prisoners. {{author}} {{($index , , , , , , , , , , , , , , , , , , , , , , & . Katrina Forsyth 1 , Leanne Heathcote 1 , Jane Senior 1, * , Baber Malik 1 , Rachel Meacock 1 , Katherine Perryman 1 , Sue Tucker 1 , Rachel

2020 NIHR HTA programme PubMed abstract

12. Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis

Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine National Center for Biotechnology Information Show account info (...) Page navigation Metabolism Actions . 2020 May 22;109:154265. doi: 10.1016/j.metabol.2020.154265. Online ahead of print. Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis , , , , Affiliations Expand Affiliations 1 Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, China. Electronic address: jbzhou@ccmu.edu.cn. 2 Beijing Tongren Hospital, Capital Medical University, China. 3 Department of Nephrology, Tongji Medical College, Huazhong

2020 EvidenceUpdates

13. Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis (Full text)

Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine (...) RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Age Ageing Actions . 2020 Jun 29;afaa090. doi: 10.1093/ageing/afaa090. Online ahead of print. Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 University of East Anglia, Norwich, UK. 2 James Paget Hospital, Gorleston, UK. 3 Aston University, Birmingham, UK. 4 University of Aberdeen, Aberdeen, UK. 5

2020 EvidenceUpdates PubMed abstract

14. Therapeutic Effects of Exercise Training on Elderly Patients With Dementia: A Randomized Controlled Trial

Therapeutic Effects of Exercise Training on Elderly Patients With Dementia: A Randomized Controlled Trial Therapeutic Effects of Exercise Training on Elderly Patients With Dementia: A Randomized Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine National (...) RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Randomized Controlled Trial Arch Phys Med Rehabil Actions . 2020 May;101(5):762-769. doi: 10.1016/j.apmr.2020.01.012. Epub 2020 Feb 19. Therapeutic Effects of Exercise Training on Elderly Patients With Dementia: A Randomized Controlled Trial , , , , , Affiliations Expand Affiliations 1 Department of Physical Medicine and Rehabilitation, Taichung Veterans General Hospital, Taichung, Taiwan. 2 Department of Neurology

2020 EvidenceUpdates

15. Advance care planning for people living with dementia: An umbrella review of effectiveness and experiences (Full text)

Advance care planning for people living with dementia: An umbrella review of effectiveness and experiences Advance Care Planning for People Living With Dementia: An Umbrella Review of Effectiveness and Experiences - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine National (...) RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Review Int J Nurs Stud Actions . 2020 Jul;107:103576. doi: 10.1016/j.ijnurstu.2020.103576. Epub 2020 Mar 20. Advance Care Planning for People Living With Dementia: An Umbrella Review of Effectiveness and Experiences , , , , , Affiliations Expand Affiliations 1 End-of-Life Care Research Group, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Brussels, Belgium. Electronic address: Annelien.van.dael@vub.be. 2 Centre

2020 EvidenceUpdates PubMed abstract

16. End of Life Care in Frailty: Dementia

End of Life Care in Frailty: Dementia End of Life Care in Frailty: Dementia | British Geriatrics Society Toggle main menu visibility Search Search Search Resources (menu position rule) Date Published: 12 May 2020 Last updated: 12 May 2020 The aim of this guidance series is to support clinicians and others to consider the needs of frail older people as they move towards the end of their lives and help them to provide high quality care. This chapter addresses specific issues which may arise (...) in people living with dementia towards the end of life. Please to view the other chapters in this series. Dementia is a condition that kills. According to one study, 1 the average life expectancy from diagnosis to death is 4.5 years, and average survival rate in this study varied from a high of 10.7 years for the youngest patients (65-69 years) to a 3.8 years for the people diagnosed after their 90 th birthday. People may die with dementia because of the dementia itself (which may lead to poor mobility

2020 British Geriatrics Society

17. Cognitive training interventions and depression in mild cognitive impairment and dementia: a systematic review and meta-analysis of randomized controlled trials

Cognitive training interventions and depression in mild cognitive impairment and dementia: a systematic review and meta-analysis of randomized controlled trials Cognitive Training Interventions and Depression in Mild Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced (...) citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Age Ageing Actions . 2020 May 6;afaa063. doi: 10.1093/ageing/afaa063. Online ahead of print. Cognitive Training Interventions and Depression in Mild Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , , , , , Affiliations Expand Affiliations 1 Department

2020 EvidenceUpdates

18. Effectiveness of different post-diagnostic dementia care models delivered by primary care: a systematic review

Effectiveness of different post-diagnostic dementia care models delivered by primary care: a systematic review Effectiveness of Different Post-Diagnostic Dementia Care Models Delivered by Primary Care: A Systematic Review - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine (...) displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Br J Gen Pract Actions . 2020 May 28;70(695):e434-e441. doi: 10.3399/bjgp20X710165. Print 2020 Jun. Effectiveness of Different Post-Diagnostic Dementia Care Models Delivered by Primary Care: A Systematic Review , , , , , , , , , , , Affiliations Expand Affiliations 1 Department of Primary Care and Population Health, University College London, London, UK. 2 Saw Swee Hock School of Public Health, National

2020 EvidenceUpdates

19. Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline (Full text)

Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline Randomized Placebo-Controlled Trial of the Effects of Aspirin on Dementia and Cognitive Decline - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine National Center for Biotechnology (...) Actions Cite Share Permalink Copy Page navigation Neurology Actions . 2020 Mar 25;10.1212/WNL.0000000000009277. doi: 10.1212/WNL.0000000000009277. Online ahead of print. Randomized Placebo-Controlled Trial of the Effects of Aspirin on Dementia and Cognitive Decline , , , , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 From the School of Public Health and Preventive Medicine (J.R., E.S., R.L.W., R.W., C.M.R., S.A.W., J.E.L., S.G.O., R.T., J.J.M.) and the Turner Institute for Brain

2020 EvidenceUpdates PubMed abstract

20. Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment: A Systematic Review and Meta-analysis. (Abstract)

Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment: A Systematic Review and Meta-analysis. The benefit of blood pressure lowering for the prevention of dementia or cognitive impairment is unclear.To determine the association of blood pressure lowering with dementia or cognitive impairment.Search of PubMed, EMBASE, and CENTRAL for randomized clinical trials published from database inception through December 31, 2019, that evaluated the association of blood (...) pressure lowering on cognitive outcomes. The control groups consisted of either placebo, alternative antihypertensive agents, or higher blood pressure targets.Data were screened and extracted independently by 2 authors. Random-effects meta-analysis models were used to report pooled treatment effects and CIs.The primary outcome was dementia or cognitive impairment. The secondary outcomes were cognitive decline and changes in cognitive test scores.Fourteen randomized clinical trials were eligible

2020 JAMA